Evidence map›Paper›PMID 26932277›Full record

ArticlePuerto Rico health sciences journal2016

Pathway Analysis using Gene-expression Profiles of HPV-positive and HPV-negative Oropharyngeal Cancer Patients in a Hispanic Population: Methodological Procedures.

Erick Suárez, Lorena González, Carlos Pérez-Mitchell, Ana P Ortiz, Maricarmen Ramírez-Sola, Jaime Acosta, Raúl D Bernabe-Dones, Carlos González-Aquino, Ingrid Montes-Rodríguez, Carmen L Cadilla

Open access · greenAbstract read
In one paragraph

Article in Puerto Rico health sciences journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Vital roles of mFrontiers in immunology · 2023
    Review
  3. Article
  4. Article
  5. Review
  6. TheClinical cancer research : an official journal of the American Association for Cancer Research · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Erick SuárezDepartment of Biostatistics and Epidemiology, Graduate School of Public Health, University of Puerto Rico Medical Sciences Campus, San Juan, PR.
Lorena GonzálezPuerto Rico Clinical and Translational Research Consortium, University of Puerto Rico Medical Sciences Campus, San Juan, PR.
Carlos Pérez-MitchellCenter for Cranial Base, Head, and Neck Surgery, HIMA Health San Pablo Group, Caguas, PR; Department of Otolaryngology, School of Medicine, University of Puerto Rico Medical Sciences Campus, San Juan, PR.
Ana P OrtizDepartment of Biostatistics and Epidemiology, Graduate School of Public Health, University of Puerto Rico Medical Sciences Campus, San Juan, PR; University of Puerto Rico Comprehensive Cancer Center, San Juan, PR.
Maricarmen Ramírez-SolaCancer Center of HIMA Health San Pablo Group, Caguas, PR.
Jaime AcostaCenter for Cranial Base, Head, and Neck Surgery, HIMA Health San Pablo Group, Caguas, PR.
Raúl D Bernabe-DonesUniversity of Puerto Rico Comprehensive Cancer Center, San Juan, PR; School of Health Professions, University of Puerto Rico Medical Sciences Campus, San Juan, PR.
Carlos González-AquinoDepartment of Otolaryngology, School of Medicine, University of Puerto Rico Medical Sciences Campus, San Juan, PR.
Ingrid Montes-RodríguezDepartment of Chemistry, University of Puerto Rico Mayagüez Campus.
Carmen L CadillaDepartment of Biochemistry, School of Medicine and RCMI Center for Genomics in Health Disparities and Rare Diseases, University of Puerto Rico Medical Sciences Campus, San Juan, PR.
University of Puerto Rico-Mayaguez · PRUniversity of Puerto Rico, Medical Sciences Campus · PR

Funding

UPR/MDACC Partnership for Excellence in Cancer Research(Parent Grant U54 CA096297)U54CA096297 · NCI · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI Ilka C Rios · 2002 to 2026
$36.9M
RISE Option III: MBRS RISE at the UPR Medical Sciences CampusR25GM061838 · NIGMS · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI CADILLA, CARMEN LYDIA · 2000 to 2021
$25.5M
UPR/MDACC Partnership for Excellence in Cancer Research (Luis Segarra supplement)U54CA096300 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Larkin Strong · 2002 to 2026
$23.8M
TECHNOLOGIES AND RESOURCES FOR CORE LABORATORIESU54MD007587 · NIMHD · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI LUCIANO, CARLOS A., WOJNA, VALERIE · 2012 to 2018
$23.2M
TRANSLATIONAL PROTEOMICS CENTERG12MD007600 · NIMHD · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI FERNANDEZ-REPOLLET, EMMA · 2012 to 2016
$11.0M
TRAINING IN COMPUTATIONAL GENOMIC EPIDEMIOLOGY OF CANCERR25CA094186 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI LI, LI · 2002 to 2016
$6.8M
RISE Enhancing Biomedical Sciences and Biomedical Engineering in Science and TechR25GM088023 · NIGMS · UNIVERSITY OF PUERTO RICO MAYAGUEZ · PI LOPEZ-GARRIGA, JUAN · 2010 to 2013
$5.0M
PUERTO RICO CENTRAL CANCER REGISTRYU58DP000782 · DP · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI FIGUEROA-VALLES, NAYDA R · 2007 to 2011
$3.0M
NCCDPHP CDC HHS 1U58DP000782-04NCCDPHP CDC HHS U58 DP000782NCI NIH HHS 5R25CA094186-08NCI NIH HHS R25 CA094186NCI NIH HHS U54 CA096297NCI NIH HHS U54CA096297NCI NIH HHS U54 CA096300NCI NIH HHS U54CA096300NIGMS NIH HHS R25 GM061838NIGMS NIH HHS R25GM061838NIGMS NIH HHS R25 GM088023NIGMS NIH HHS R25GM088023NIMHD NIH HHS 2U54MD007587NIMHD NIH HHS G12 MD007600NIMHD NIH HHS G12MD007600NIMHD NIH HHS U54 MD007587
6 · The paper itself

Abstract

objectiveThe incidence of oral cavity and pharyngeal cancer in Puerto Rican men is higher than it is in the men of any other ethnic/racial group in the United States of America (US). The information regarding the effect of the human papilloma virus (HPV) in the gene-expression profile among patients with this cancer is limited in Hispanic community. We aim to describe the methodology for future studies to identify the molecular networks for determining overrepresented signaling and metabolic canonical pathways, based on the differential gene-expression profiles of HPV+ and HPV- samples from patients with oropharyngeal squamous cell carcinoma in Puerto Rico.

methodsWe analyzed the RNA expression of 5 tissue samples from subjects diagnosed with oropharyngeal squamous cell carcinoma, 2 HPV+ and 3 HPV-, using Affymetrix GeneChips. The relative difference between the average gene expressions of the HPV+ and HPV- samples was assessed, based on the fold change (log2-scale).

resultsOur analysis revealed 10 up regulated molecules (Mup1, LRP1, P14KA, ALYREF, and BHMT) and 5 down regulated ones (PSME4, KEAP1, ELK3, FAM186B, and PRELID1), at a cutoff of 1.5-fold change. Ingenuity Pathway Analysis showed the following biological functions to be affected in the HPV+ samples: cancer, hematological disease, and RNA post-transcriptional modification. QRT-PCR analysis confirmed only the differential regulation of ALYREF, KEAP1, and FAM186B genes.

conclusionThe relevant methodological procedures described are sufficient to detect the most significant biological functions and pathways according to the HPV status in patients with oropharyngeal cancer in Puerto Rico.

Indexed as

Gene Expression Regulation, NeoplasticAgedCarcinoma, Squamous CellFemaleGene Expression ProfilingHead and Neck NeoplasmsHispanic or LatinoHumansMaleOligonucleotide Array Sequence AnalysisOropharyngeal NeoplasmsPapillomaviridaePapillomavirus InfectionsPuerto RicoReverse Transcriptase Polymerase Chain ReactionRNA Processing, Post-TranscriptionalGene expressionHPVMicroarraysNetwork analysisOropharyngeal cancerPuerto Rico

Identifiers

PMID26932277
PMCPMC4999560
OpenAlexW2282748347

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.